These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 37371141)

  • 1. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds.
    Roy T; Boateng ST; Uddin MB; Banang-Mbeumi S; Yadav RK; Bock CR; Folahan JT; Siwe-Noundou X; Walker AL; King JA; Buerger C; Huang S; Chamcheu JC
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.
    Tewari D; Patni P; Bishayee A; Sah AN; Bishayee A
    Semin Cancer Biol; 2022 May; 80():1-17. PubMed ID: 31866476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.
    Chamcheu JC; Roy T; Uddin MB; Banang-Mbeumi S; Chamcheu RN; Walker AL; Liu YY; Huang S
    Cells; 2019 Jul; 8(8):. PubMed ID: 31370278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
    Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
    Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy.
    Narayanankutty A
    Curr Top Med Chem; 2021; 21(20):1816-1831. PubMed ID: 34279200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
    Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
    Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide-3 kinase/protein kinase-B/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target?
    Huang T; Lin X; Meng X; Lin M
    Acta Derm Venereol; 2014 Jul; 94(4):371-9. PubMed ID: 24217655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
    Chamcheu JC; Esnault S; Adhami VM; Noll AL; Banang-Mbeumi S; Roy T; Singh SS; Huang S; Kousoulas KG; Mukhtar H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
    Shorning BY; Dass MS; Smalley MJ; Pearson HB
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.
    Martelli AM; Evangelisti C; Chiarini F; McCubrey JA
    Oncotarget; 2010 Jun; 1(2):89-103. PubMed ID: 20671809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.
    Sun H; Wang Z; Yakisich JS
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1048-56. PubMed ID: 23293890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response.
    Mohseni AH; Casolaro V; Bermúdez-Humarán LG; Keyvani H; Taghinezhad-S S
    Gut Microbes; 2021; 13(1):1-17. PubMed ID: 33615993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer.
    Meuten TK; Dean GA; Thamm DH
    Vet Pathol; 2024 May; 61(3):339-356. PubMed ID: 37905509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.
    Ciruelos Gil EM
    Cancer Treat Rev; 2014 Aug; 40(7):862-71. PubMed ID: 24774538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products.
    Iksen ; Pothongsrisit S; Pongrakhananon V
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
    Chen J; Yuan S; Zhou J; Huang X; Wu W; Cao Y; Liu H; Hu Q; Li X; Guan X; Yin S; Jiang J; Zhou Y; Zhou J
    Phytomedicine; 2022 Dec; 107():154477. PubMed ID: 36215790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment.
    Raith F; O'Donovan DH; Lemos C; Politz O; Haendler B
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.